Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rajasthan Antibiotics is an Indian integrated pharmaceutical manufacturer focused on sterile active pharmaceutical ingredients and finished dosage formulations. The company began commercial production in 1991 and is known in India for sterile beta-lactam antibiotics and sterile anti-ulcer products, with dedicated crystalline and lyophilized manufacturing blocks. Its marketed portfolio and API supply capabilities include products such as ampicillin sodium sterile, meropenem, piperacillin + tazobactam, omeprazole sodium sterile, pantoprazole sodium sterile, acyclovir, and other injectable or sterile small-molecule products. Rajasthan Antibiotics appears to operate primarily as a commercial-stage pharma manufacturing business rather than a clinical-stage biotech developer, with export activity and regulatory filings supporting international supply.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Rajasthan Antibiotics.